Myocardial oxidative stress, osteogenic phenotype, and energy metabolism are differentially involved in the initiation and early progression of delta-sarcoglycan-null cardiomyopathy.

Myocardial oxidative stress, osteogenic phenotype, and energy metabolism are differentially involved in the initiation and early progression of delta-sarcoglycan-null cardiomyopathy.

Item
http://www.wikidata.org/entity/Q42255196
Activation of host tissue trophic factors through JAK-STAT3 signaling: a mechanism of mesenchymal stem cell-mediated cardiac repair.Basal bioenergetic abnormalities in skeletal muscle from ryanodine receptor malignant hyperthermia-susceptible R163C knock-in mice.Intramuscular VEGF activates an SDF1-dependent progenitor cell cascade and an SDF1-independent muscle paracrine cascade for cardiac repairHigh-sugar intake does not exacerbate metabolic abnormalities or cardiac dysfunction in genetic cardiomyopathyTissue-nonspecific alkaline phosphatase as a target of sFRP2 in cardiac fibroblasts.Activation of Toll-like receptor 3 amplifies mesenchymal stem cell trophic factors and enhances therapeutic potency.Marine n3 polyunsaturated fatty acids enhance resistance to mitochondrial permeability transition in heart failure but do not improve survival.Heart failure therapy mediated by the trophic activities of bone marrow mesenchymal stem cells: a noninvasive therapeutic regimenMuscular dystrophy therapy by nonautologous mesenchymal stem cells: muscle regeneration without immunosuppression and inflammationIntramuscular VEGF repairs the failing heart: role of host-derived growth factors and mobilization of progenitor cells.Vascular endothelial growth factor (VEGF) as a key therapeutic trophic factor in bone marrow mesenchymal stem cell-mediated cardiac repairSecreted Frizzled-related protein 2 as a target in antifibrotic therapeutic intervention.
P2860

Myocardial oxidative stress, osteogenic phenotype, and energy metabolism are differentially involved in the initiation and early progression of delta-sarcoglycan-null cardiomyopathy.

Item
http://www.wikidata.org/entity/Q42255196
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Myocardial oxidative stress, o ...... rcoglycan-null cardiomyopathy.
@en
Myocardial oxidative stress, o ...... rcoglycan-null cardiomyopathy.
@nl
type
label
Myocardial oxidative stress, o ...... rcoglycan-null cardiomyopathy.
@en
Myocardial oxidative stress, o ...... rcoglycan-null cardiomyopathy.
@nl
prefLabel
Myocardial oxidative stress, o ...... rcoglycan-null cardiomyopathy.
@en
Myocardial oxidative stress, o ...... rcoglycan-null cardiomyopathy.
@nl
P1433
P1476
P2093
P2860
P2888
P304
P31
P356
P433
P478
P577
P5875
P698
P932
P356
P1433
P1476
Myocardial oxidative stress, o ...... rcoglycan-null cardiomyopathy.
@en
P2093
P2860
P2888
P304
P31
P356
P433
P478
P577
P5875
P698
P932